Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Amortization of Deferred Charges (2016 - 2025)

Dexcom (DXCM) has disclosed Amortization of Deferred Charges for 11 consecutive years, with $1.7 million as the latest value for Q4 2025.

  • Quarterly Amortization of Deferred Charges fell 10.53% to $1.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.3 million through Dec 2025, down 2.67% year-over-year, with the annual reading at $7.3 million for FY2025, 2.67% down from the prior year.
  • Amortization of Deferred Charges for Q4 2025 was $1.7 million at Dexcom, down from $1.9 million in the prior quarter.
  • The five-year high for Amortization of Deferred Charges was $2.2 million in Q3 2023, with the low at $1.4 million in Q4 2021.
  • Average Amortization of Deferred Charges over 5 years is $1.8 million, with a median of $1.8 million recorded in 2024.
  • The sharpest move saw Amortization of Deferred Charges dropped 23.81% in 2022, then soared 46.67% in 2023.
  • Over 5 years, Amortization of Deferred Charges stood at $1.4 million in 2021, then rose by 14.29% to $1.6 million in 2022, then grew by 25.0% to $2.0 million in 2023, then dropped by 5.0% to $1.9 million in 2024, then dropped by 10.53% to $1.7 million in 2025.
  • According to Business Quant data, Amortization of Deferred Charges over the past three periods came in at $1.7 million, $1.9 million, and $1.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.